(1888PressRelease) The time to file a claim for compensation forchildren born with congenital heart defects as a result of exposureto Paxil is running out.New York, NY – It appears that the time to seek compensation forbirth defects allegedly caused by exposure to the antidepressantPaxil during pregnancy is running out. DrugSettlement.com reportsthat court records indicate many cases have been resolved and havebeen removed from the docket. Parents who took Paxil duringpregnancy and gave birth to a child with a congenital heart defectshould act quickly to determine whether they my file a claim onbehalf of their child.Parents may visit www.DrugSettlement.com for more information.No Paxil birth defect cases have been tried since the October 13,2009, verdict where a jury awarded $2.5M to the family of LyamKilker, a child born with a congenital heart defect caused by Paxiluse during pregnancy. Though multiple trials were scheduled forDecember, January and February, not one even began trial. It ispresumed that these cases, all alleging heart birth defects causedby exposure to Paxil during pregnancy, were settled by GSK.Since Paxil came on the market in 1992, if has faced threesignificant litigations. GSK resolved approximately150 suicidecases reportedly for an average of $2 million. Other casesincluding 300 cases where it was alleged that consumers attemptedsuicide were settled for approximately $300,000, according to aDecember 14, 2009 report by Bloomberg News.In cases alleging withdrawal problems, GSK faced approximately 3200cases for which it settled for an average of about $50,000.GSK has also paid about $400 million to end antitrust, fraud anddesign claims, Bloomberg reports. Since 1992, Glaxo has paid outclose to $1 billion to resolve Paxil lawsuits. It has been reportedthat it may now be trying to resolve the nearly 800 birth defectcases now confronting it.Source:http://www.1888pressrelease.com/the-time-to-file-a-paxil-birth-defect-claim-is-running-out-pr-194252.html
